TY - JOUR
T1 - Predictors of ventricular pacing burden after permanent pacemaker implantation following transcatheter aortic valve replacement
AU - Elzeneini, Mohammed
AU - Assaf, Yazan
AU - Aalaei-Andabili, Seyed Hossein
AU - Mahmoud, Ahmad
AU - Hamburger, Robert
AU - Goel, Ramil
AU - Bavry, Anthony A.
N1 - Funding Information:
The article publication charge will be covered by the North Florida Foundation for Research and Education.
Publisher Copyright:
© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
PY - 2020/11
Y1 - 2020/11
N2 - Background: In the era of an expanding use of transcatheter aortic valve replacement (TAVR), conduction disturbances and the requirement for permanent pacemaker (PPM) implantation remains a clinical concern. Hypothesis: Using a single-center experience, we sought to identify predictors of ventricular pacing burden after TAVR in patients who required PPM implantation. Methods: We conducted a retrospective study of 359 consecutive patients with symptomatic severe aortic valve stenosis who underwent TAVR at our institution between September 2013 and July 2019. Thirty patients (8.4%) required a PPM within 30 days after TAVR. Pre and post-TAVR electrocardiograms, pre-TAVR echocardiograms and computed tomography (CT), TAVR procedural details and post-TAVR device interrogation records at 1, 3, and 6 months were reviewed. Results: Mean percentage of ventricular pacing (VP%) at 1, 3, and 6 months was 58%, 59%, and 56% respectively. Using univariate logistic regression analysis, patients who had low VP% < 5% at 6 months were more likely to have a prosthesis/echocardiography-derived left ventricular outflow tract (LVOT) diameter ratio < 1.3 (OR 7.00, P-value.048), prosthesis/CT-derived aortic annulus diameter ratio < 1.02 (OR 7.11, P-value.047), post-TAVR new-onset LBBB (OR 16.80, P-value.019), time to PPM implantation greater than 2 days post-TAVR (OR 9.38, P-value.026) and pre-TAVR use of a beta blocker (OR 9.40, P-value.026). Conclusions: In patients who required a PPM implantation post-TAVR, a lower TAVR prosthesis/LVOT or aortic annulus diameter ratio, post-TAVR new-onset LBBB and later time of PPM implantation showed a trend toward predicting a low VP% at 6 months.
AB - Background: In the era of an expanding use of transcatheter aortic valve replacement (TAVR), conduction disturbances and the requirement for permanent pacemaker (PPM) implantation remains a clinical concern. Hypothesis: Using a single-center experience, we sought to identify predictors of ventricular pacing burden after TAVR in patients who required PPM implantation. Methods: We conducted a retrospective study of 359 consecutive patients with symptomatic severe aortic valve stenosis who underwent TAVR at our institution between September 2013 and July 2019. Thirty patients (8.4%) required a PPM within 30 days after TAVR. Pre and post-TAVR electrocardiograms, pre-TAVR echocardiograms and computed tomography (CT), TAVR procedural details and post-TAVR device interrogation records at 1, 3, and 6 months were reviewed. Results: Mean percentage of ventricular pacing (VP%) at 1, 3, and 6 months was 58%, 59%, and 56% respectively. Using univariate logistic regression analysis, patients who had low VP% < 5% at 6 months were more likely to have a prosthesis/echocardiography-derived left ventricular outflow tract (LVOT) diameter ratio < 1.3 (OR 7.00, P-value.048), prosthesis/CT-derived aortic annulus diameter ratio < 1.02 (OR 7.11, P-value.047), post-TAVR new-onset LBBB (OR 16.80, P-value.019), time to PPM implantation greater than 2 days post-TAVR (OR 9.38, P-value.026) and pre-TAVR use of a beta blocker (OR 9.40, P-value.026). Conclusions: In patients who required a PPM implantation post-TAVR, a lower TAVR prosthesis/LVOT or aortic annulus diameter ratio, post-TAVR new-onset LBBB and later time of PPM implantation showed a trend toward predicting a low VP% at 6 months.
KW - pacemaker dependency
KW - pacemaker independency
KW - transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85090159505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090159505&partnerID=8YFLogxK
U2 - 10.1002/clc.23447
DO - 10.1002/clc.23447
M3 - Article
C2 - 32886389
AN - SCOPUS:85090159505
SN - 0160-9289
VL - 43
SP - 1334
EP - 1342
JO - Clinical Cardiology
JF - Clinical Cardiology
IS - 11
ER -